Prana to commence Phase 1 clinical trial of PBT434 for treatment of parkinsonian diseases June 13, 2018August 16, 2022
Alterity Therapeutics Receives Regulatory Authorization in France and Austria to Proceed with ATH434 Phase 2 Clinical Trial February 16, 2023May 23, 2023
